Four Generic Products (global rights) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Four Generic Products (global rights) General Information

Description

Portfolio of global rights related to four generic pharmaceuticals. The products include sodium feredetate oral solution for the treatment of anemia, trazadone oral solution for the treatment of depression and two additional pipeline products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Primary Office
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Four Generic Products (global rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Four Generic Products (global rights)‘s full profile, request access.

Request a free trial